Trial Profile
Phase I/II Trial Of CCI-779 In Patients With Malignant Glioma
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 02 Jul 2018
Price :
$35
*
At a glance
- Drugs Temsirolimus (Primary)
- Indications Anaplastic astrocytoma; Astrocytoma; Glioblastoma; Glioma; Oligodendroglioma
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 22 Jun 2018 Planned number of patients changed from 123 to 49.
- 19 Aug 2005 New trial record.